Akari Therapeutics to Present RNA-Splicing ADC Payload Strategy
Akari Therapeutics says its presentation at the 3rd Annual ADC Payload Summit will discuss RNA-splicing payloads, potential anti-tumor effects and preclinical findings.
Akari Therapeutics says its presentation at the 3rd Annual ADC Payload Summit will discuss RNA-splicing payloads, potential anti-tumor effects and preclinical findings.